午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook
English   Japanese   Germany   Korea

N-(3-pyridylmethyl)adriamycin

, 145785-62-2, 結(jié)構(gòu)式
CAS號(hào):
145785-62-2
英文名:
N-(3-pyridylmethyl)adriamycin
英文別名:
Ym-1;Ym 1;N-(3-pyridylmethyl)adriamycin;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-((3-pyridinylmethyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-;5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(3-pyridinylmethyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)- (9CI)
中文名:
中文別名:
CBNumber:
CB11304496
分子式:
C33H34N2O11
分子量:
634.63
MOL File:
145785-62-2.mol

N-(3-pyridylmethyl)adriamycin化學(xué)性質(zhì)

安全信息

N-(3-pyridylmethyl)adriamycin性質(zhì)、用途與生產(chǎn)工藝

N-(3-pyridylmethyl)adriamycin 上下游產(chǎn)品信息

上游原料

下游產(chǎn)品

N-(3-pyridylmethyl)adriamycin 試劑級(jí)價(jià)格

更新日期產(chǎn)品編號(hào)產(chǎn)品名稱CAS編號(hào)包裝價(jià)格
2025/02/08HY-18399YM-1145785-62-25 mg1500元
2025/02/08HY-18399YM-1145785-62-210 mg2500元

N-(3-pyridylmethyl)adriamycin 生產(chǎn)廠家

全球有 1家供應(yīng)商   N-(3-pyridylmethyl)adriamycin國(guó)內(nèi)生產(chǎn)廠家
供應(yīng)商聯(lián)系電話電子郵件國(guó)家產(chǎn)品數(shù)優(yōu)勢(shì)度
CHEMICAL LAND21 sales21@chemicalland21.com 韓國(guó) 6303 74
 

145785-62-2, N-(3-pyridylmethyl)adriamycin 相關(guān)搜索:

  • C33H34N2O11
  • 145785-62-2
  • 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(3-pyridinylmethyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)- (9CI)
  • Ym-1
  • Ym 1
  • 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-((3-pyridinylmethyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-
  • N-(3-pyridylmethyl)adriamycin
本網(wǎng)站展示的所有產(chǎn)品僅用于工業(yè)應(yīng)用或者科學(xué)研究等非醫(yī)療目的,不可用于人類(lèi)或動(dòng)物的臨床診斷或者治療,非藥用,非食用。
根據(jù)相關(guān)法律法規(guī)和本站規(guī)定，單位或個(gè)人購(gòu)買(mǎi)相關(guān)危險(xiǎn)物品應(yīng)取得有效的資質(zhì)、資格條件。
Copyright 2016 © ChemicalBook. All rights reserved